The primary endpoint of 12-month Event Free Survival (EFS) for OST-HER2- treated patients (33.3%) was statistically significant (p= 0.0158) when compared with peer-reviewed comparable historical...
The primary endpoint of 12-month Event Free Survival (EFS) for OST-HER2- treated patients (33.3%) was statistically significant (p= 0.0158) when compared with peer-reviewed comparable historical...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.3199 | -43.5253283302 | 5.33 | 7 | 2.98 | 3946189 | 4.35423051 | CS |
4 | -0.7099 | -19.0833333333 | 3.72 | 7 | 2.98 | 1207517 | 4.35998457 | CS |
12 | 0.0301 | 1.01006711409 | 2.98 | 7 | 1.58 | 413946 | 4.26000101 | CS |
26 | -0.9899 | -24.7475 | 4 | 7 | 1.58 | 288035 | 4.10430957 | CS |
52 | -0.9899 | -24.7475 | 4 | 7 | 1.58 | 288035 | 4.10430957 | CS |
156 | -0.9899 | -24.7475 | 4 | 7 | 1.58 | 288035 | 4.10430957 | CS |
260 | -0.9899 | -24.7475 | 4 | 7 | 1.58 | 288035 | 4.10430957 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관